Celestone and Synthroid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Celestone (betamethasone) and Synthroid (levothyroxine sodium). Common drug interactions include osteoarthritis among females and cellulitis among males.
The phase IV clinical study analyzes what interactions people have when they take Celestone and Synthroid. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.
What is Celestone?
Celestone has active ingredients of betamethasone. It is often used in bursitis. eHealthMe is studying from 1,788 Celestone users. Check the latest studies of Celestone.
What is Synthroid?
Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 249,198 Synthroid users. Check the latest studies of Synthroid.
49 people who take Celestone and Synthroid together, and have interactions are studied.

What are the common drug interactions of Celestone and Synthroid, by gender? *:
female:
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Speech disorder
- Throat irritation
- Osteonecrosis (death of bone)
- Renal cyst (kidney cyst)
- Scoliosis (a medical condition in which a person's spine is curved from side to side)
- Spinal haemangioma (an abnormal, but non cancer blood vessel tumour that commonly occurs in the spine)
- Chest pain
- Weight increased
- Constipation
male:
- Cellulitis (infection under the skin)
- Pain
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Dental caries
- Disability
- Dyspepsia (indigestion)
- Epicondylitis (tennis elbow)
- Erythema (redness of the skin)
- Gastritis erosive (a break in the surface layer of the membrane lining the stomach with infection)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
What are the common drug interactions of Celestone and Synthroid, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Back pain
- Chest pain
- Dyspnoea (difficult or laboured respiration)
- Headache (pain in head)
- Pain
- Pulmonary embolism (blockage of the main artery of the lung)
- Drug exposure during pregnancy
- Premature labour
30-39:
n/a
40-49:
- Anxiety
- Bone disorder
- Depression
- Eating disorder
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
- Nephrolithiasis (calculi in the kidneys)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Pain
50-59:
- Thirst
- Weight increased
- Blood glucose increased
- Device failure
- Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Injection site erythema (redness at injection site)
- Insulin resistance
- Road traffic accident
- Skin infection
60+:
- Cellulitis (infection under the skin)
- Anxiety
- Breast mass
- Calculus ureteric (stone in ureter)
- Costochondritis (chest wall pain)
- Dental caries
- Disability
- Dyspepsia (indigestion)
- Epicondylitis (tennis elbow)
- Erythema (redness of the skin)
What are the existing conditions these people have? *
- Pain: 12 people, 24.49%
- Seasonal Allergy (allergic condition due to certain season): 9 people, 18.37%
- Osteoporosis (bones weak and more likely to break): 9 people, 18.37%
- Multiple Myeloma (cancer of the plasma cells): 9 people, 18.37%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 5 people, 10.20%
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 8.16%
- Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 6.12%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 6.12%
- Hypersensitivity: 3 people, 6.12%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.12%
* Approximation only. Some reports may have incomplete information.
Do you take Celestone and Synthroid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Celestone and Synthroid:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Celestone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Synthroid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Celestone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Synthroid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on betamethasone and levothyroxine sodium (the active ingredients of Celestone and Synthroid, respectively), and Celestone and Synthroid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Potassium Chloride cause Malignant Neoplasm Progression? - a second ago
- Azor vs. Vasotec, side effect and effectiveness comparison - 5 seconds ago
- Could Emend cause Malignant Neoplasm Progression? - 7 seconds ago
- Could Vinorelbine Tartrate cause Malignant Neoplasm Progression? - 13 seconds ago
- Could Atacand cause Dry Skin? - 15 seconds ago
- Could Sunitinib Malate cause Malignant Neoplasm Progression? - 17 seconds ago
- Could Torsemide cause Lactic Acidosis? - 20 seconds ago
- Drug interactions of Atacand and Procardia Xl - 20 seconds ago
- Could Tobradex cause Seasonal Allergy? - 24 seconds ago
- Could Xarelto cause Patella Fracture? - 28 seconds ago